Moleculin Biotech MBRX
NASDAQ MBRX
$0.49 -0.01 (-2.00%)
At close: Oct 2, 2026 · 4:00 PM EDT

Moleculin Biotech (MBRX) Other Accumulated Expenses (2016 - 2020)

Updated

Moleculin Biotech (MBRX) recorded Other Accumulated Expenses of $84,000 in Q4 2020, down 48.8% from $164,000 a year earlier but up 50.0% from the prior quarter.

Analysis

Moleculin Biotech (MBRX) Other Accumulated Expenses (2016 - 2020) Analysis & Trends

Starting with Q2 2016, Moleculin Biotech's Other Accumulated Expenses history includes 5 quarters.

  • Across earlier years, Other Accumulated Expenses came in at $164,000 in FY2019.
  • Quarterly Other Accumulated Expenses has ranged from $37,500 in Q3 2016 to $164,000 in Q4 2019 over the past five years.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn
10 Moleculin Biotech 2.78 Mn 2.78 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2020 84,000.00
Sep 30, 2020 56,000.00
Dec 31, 2019 164,000.00
Sep 30, 2016 37,500.00
Jun 30, 2016 100,000.00
API Access

Moleculin Biotech Other Accumulated Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=MBRX&period=max&api_key=YOUR_API_KEY